Online Iclusig (Ponatinib) Tablets


Medical Evidence Iclusig

Generic name : Ponatinib.

Trade name : Iclusig.

Manufacturer information :

Iclusig is manufactured by Ariad Pharmaceuticals, Inc.

Iclusig FDA Approval:

Iclusig first approved December 14th, 2012.

Iclusig Dosage form :

Tablets: 15 mg and 45 mg.

Iclusig Indications and Usage :

Chronic Myeloid Leukemia

Indicated for patients with chronic, accelerated, or blast phase T315I-positive chronic myeloid leukemia (CML) for whom no other TKI therapy is indicated.

Iclusig (Ponatinib) availability in India

  • You could import this medicine against import permit on Patient Name.
  • Please contact ACT Lifesciences Private Limited for further information.